These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 6188905)
21. Frequency- and voltage-dependent effects of disopyramide in canine Purkinje fibers. Flemming MA; Sasyniuk BI Can J Physiol Pharmacol; 1989 Jul; 67(7):710-21. PubMed ID: 2766102 [TBL] [Abstract][Full Text] [Related]
22. Nicorandil shortens action potential duration and antagonises the reduction of Vmax by lidocaine but not by disopyramide in guinea-pig papillary muscles. Kojima M; Ban T Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):203-12. PubMed ID: 2966899 [TBL] [Abstract][Full Text] [Related]
23. Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade. Honerjäger P; Loibl E; Steidl I; Schönsteiner G; Ulm K Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):184-95. PubMed ID: 2422563 [TBL] [Abstract][Full Text] [Related]
24. New observations on the mechanisms of antiarrhythmic actions of disopyramide on cardiac membranes. Hiraoka M; Kuga K; Kawano S; Sunami A; Fan Z Am J Cardiol; 1989 Dec; 64(20):15J-19J. PubMed ID: 2596408 [TBL] [Abstract][Full Text] [Related]
25. Effects of disopyramide on transmembrane action potentials in guinea-pig papillary muscles. Kojima M Eur J Pharmacol; 1981 Jan; 69(1):11-24. PubMed ID: 7202508 [TBL] [Abstract][Full Text] [Related]
26. Frequency- and voltage-dependent depression of maximum upstroke velocity of action potentials by pirmenol in guinea pig ventricular muscles. Nakaya H; Tohse N; Kanno M Jpn J Pharmacol; 1988 Dec; 48(4):423-34. PubMed ID: 3244198 [TBL] [Abstract][Full Text] [Related]
27. Effects of hyperkalemia, acidosis, and hypoxia on the depression of maximum rate of depolarization by class I antiarrhythmic drugs in guinea pig myocardium: differential actions of class Ib and Ic agents. Campbell TJ; Wyse KR; Hemsworth PD J Cardiovasc Pharmacol; 1991 Jul; 18(1):51-9. PubMed ID: 1719292 [TBL] [Abstract][Full Text] [Related]
28. Cellular electrophysiological properties of a new aminosteroid antiarrhythmic agent, SC-35135. Borowicz LE; Martin CL; Sanguinetti MC J Cardiovasc Pharmacol; 1988 Aug; 12(2):218-26. PubMed ID: 2459553 [TBL] [Abstract][Full Text] [Related]
29. Recovery from use-dependent block of Vmax and restitution of action potential duration in canine cardiac Purkinje fibers. Elharrar V J Pharmacol Exp Ther; 1988 Jul; 246(1):235-42. PubMed ID: 3392655 [TBL] [Abstract][Full Text] [Related]
30. Blockage of the sodium current in isolated single cells from rat ventricle with mexiletine and disopyramide. Yatani A; Akaike N J Mol Cell Cardiol; 1985 May; 17(5):467-76. PubMed ID: 2411942 [TBL] [Abstract][Full Text] [Related]
31. Coupling interval-related effects of class I antiarrhythmic drugs, mexiletine, cibenzoline and disopyramide, on ventricular activation in canine myocardial infarction. Hashimoto H; Satoh N; Nakashima M Jpn J Pharmacol; 1991 Dec; 57(4):463-72. PubMed ID: 1803064 [TBL] [Abstract][Full Text] [Related]
32. Frequency and voltage-dependent effects of mono-N-dealkyldisopyramide, the major metabolite of disopyramide, in canine ventricular tissue. Toy W; Sasyniuk BI J Pharmacol Exp Ther; 1990 Aug; 254(2):603-11. PubMed ID: 2166798 [TBL] [Abstract][Full Text] [Related]
34. Use-dependent effects of pirmenol on Vmax and conduction in guinea-pig ventricular myocardium. Hasegawa J; Hirai S; Noguchi N; Hisatome I; Kotake H; Mashiba H Br J Pharmacol; 1990 Apr; 99(4):815-9. PubMed ID: 2361175 [TBL] [Abstract][Full Text] [Related]
35. Effects of disopyramide on the maximum rate of rise of action potential (Vmax) in guinea-pig papillary muscles. Kojima M; Ban T; Sada H Jpn J Pharmacol; 1982 Feb; 32(1):91-102. PubMed ID: 7087266 [TBL] [Abstract][Full Text] [Related]
36. [Experimental studies on the antiarrhythmic mechanism of mexiletine in guinea pig ventricular muscles using microelectrode techniques]. Matsuo S Nihon Ika Daigaku Zasshi; 1984 Apr; 51(2):208-23. PubMed ID: 6330160 [No Abstract] [Full Text] [Related]
37. Use-dependent blocking action of newly developed lidocaine-analogs on maximum rate of rise of action potentials in guinea pig papillary muscle. Toyama J; Kodama I; Kusunoki T; Ishihara T; Hattori Y; Yamada K Jpn Heart J; 1987 Mar; 28(2):273-85. PubMed ID: 3110457 [TBL] [Abstract][Full Text] [Related]
38. Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium. Hézső T; Naveed M; Dienes C; Kiss D; Prorok J; Árpádffy-Lovas T; Varga R; Fujii E; Mercan T; Topal L; Kistamás K; Szentandrássy N; Almássy J; Jost N; Magyar J; Bányász T; Baczkó I; Varró A; Nánási PP; Virág L; Horváth B Sci Rep; 2021 May; 11(1):9565. PubMed ID: 33953276 [TBL] [Abstract][Full Text] [Related]
39. Effects of the enantiomers of disopyramide and its major metabolite on the electrophysiological characteristics of the guinea-pig papillary muscle. Vanhoutte F; Vereecke J; Carmeliet E; Verbeke N Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):662-73. PubMed ID: 1775199 [TBL] [Abstract][Full Text] [Related]
40. Kinetics of frequency-dependent conduction delay by class I antiarrhythmic drugs in human atrium. Sakai R; Inoue D; Ishibashi K; Inoue M; Shirayama T; Yamahara Y; Asayama J; Nakagawa M J Cardiovasc Pharmacol; 1995 Jun; 25(6):953-60. PubMed ID: 7564341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]